Acarbose Tablets 25 mg Exporter in India – Healthy Inc

Acarbose Tablets 25 mg | Exporter
Product image for Acarbose Tablets 25 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Acarbose |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | USP / IP |
| Product Type | Tablet |
| Category | Antidiabetic Drugs |
| Subcategory | Alpha-Glucosidase Inhibitors |
| Active Ingredient | Acarbose |
| Strength | 25 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antidiabetic Drugs - Alpha-Glucosidase Inhibitors |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Acarbose Tablets 25 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Monotherapy or adjunctive therapy to diet and exercise in patients with type 2 diabetes mellitus (T2DM). 2. Combination therapy with metformin, sulfonylureas, or insulin when single agents fail to achieve glycemic targets. 3. Prevention of type 2 diabetes in individuals diagnosed with impaired glucose tolerance (prediabetes). | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Acarbose Tablets 25 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Acarbose Tablets 25 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally immediately before meals or chewed with the very first mouthful of food. Recommended starting dosage: 25 mg or 50 mg once to thrice daily with main meals. Titrate upward at 4 to 8-week intervals based on 1-hour and 2-hour postprandial glucose and HbA1c levels, up to a maximum dose of 100 mg three times daily to minimize gastrointestinal discomfort. | ||||||||||||||||||||||||
| Side Effects | Very Common (>10%): Flatulence, abdominal distension, borborygmi (intestinal rumbling). Common (1-10%): Diarrhea, abdominal cramps, mild nausea. Uncommon to Rare (<1%): Transient asymptomatic hepatic transaminase elevation, allergic dermatitis, erythema, exanthema, ileus or subileus. | ||||||||||||||||||||||||
| Warnings and Precautions | Hypoglycemia Management: If hypoglycemia develops when taken concomitantly with a sulfonylurea or insulin, administer oral glucose (dextrose) directly. Table sugar (sucrose) is ineffective due to acarbose-mediated sucrase inhibition. Hepatic Monitoring: Monitor serum transaminases periodically during the first 6 to 12 months of therapy. Renal Impairment: Not recommended in severe renal failure (serum creatinine > 2.0 mg/dL or creatinine clearance < 25 mL/min). | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to acarbose or tablet excipients. 2. Inflammatory bowel disease (Crohn's disease, ulcerative colitis), severe intestinal ulceration, or chronic malabsorption syndromes. 3. Partial or complete intestinal obstruction, or conditions predisposing to bowel obstruction (e.g., Roemheld syndrome, large abdominal hernias). 4. Severe renal impairment (CrCl < 25 mL/min). 5. Diabetic ketoacidosis or diabetic hyperosmolar state. | ||||||||||||||||||||||||
| Drug Interactions | 1. Digestive Enzymes & Adsorbents: Intestinal adsorbents (charcoal) and amylase/pancreatin preparations diminish acarbose activity; avoid concurrent administration. 2. Sulfonylureas & Insulin: Potentiates hypoglycemic risk; downward dosage adjustment of insulin secretagogues may be required. 3. Digoxin: Acarbose reduces plasma bioavailability of digoxin; monitor serum digoxin levels. 4. Thiazide Diuretics & Corticosteroids: Antagonize glycemic control, requiring acarbose dose titration. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Acarbose Tablets 25 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Acarbose Tablets 25 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Acarbose Tablets 25 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Acarbose Tablets 25 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Acarbose Tablets 25 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products












